Teva CEO Talks Drug Pricing, Generics, Supply Shortages
Bloomberg Talks
00:00
Exploring Drug Pricing and the Future of GLP-1 Generics
This chapter delves into the complexities of drug pricing in the U.S., examining the impact of prescription rates and supply dynamics. It also highlights the advent of generic GLP-1 drugs and the significance of strategic capital allocation in fostering innovation.
Transcript
Play full episode
